Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 四川科伦药业股份有限公司是一家专注于医药输液行业的研发和创新的企业.其主要产品涵盖了输液、粉针、小水针、片剂、胶囊剂等多种剂型.公司是国内输液行业的领导者,国内产业链最为完美的大型医药集团之一.2006年科伦药业的主导产品大输液的产销量超过14亿瓶袋,是中国最大的输液专业制造商,中国医药企业50强。
Main Business 从事大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液等25种剂型药品及抗生素中间体、原料药、医药包材、医疗器械等产品的研发、生产和销售。
Legal Representative 刘革新
Top Executives
董事长：刘革新
董事：周显祥,葛均友,王广基,贺国生,刘思川
独立董事：高金波,任世驰,王福清
Top 5 Shareholder
Shareholder name Nature Holding Date
刘革新限售股+流通A股23.67%30/09/2024
雅安市国有资产经营有限责任公司流通A股5.86%30/09/2024
香港中央结算有限公司流通A股5.17%30/09/2024
中国建设银行股份有限公司－工银瑞信前沿医疗股票型证券投资基金流通A股1.25%30/09/2024
中国工商银行股份有限公司－中欧医疗健康混合型证券投资基金流通A股0.99%30/09/2024
Company Secretary 冯昊
Solicitors 北京市金杜律师事务所
Auditors 毕马威华振会计师事务所
Tel No 028-82860516;028-82860678
Fax No 028-86132515
Website www.kelun.com
Email kelun@kelun.com；fengh@kelun.com；?wangmr@kelun.com
Company Address
Register: 成都市新都区工业大道东段520号
Office: 四川省成都市青羊区百花西路36号
Listing Date 03/06/2010
Shares Capital
Shares Capital: 1,601,592,173
Total A Share: 1,601,592,173
Listed A Share: 1,308,662,081
Non-tradable A Share: 292,930,092
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.690
DPS(RMB)* ¥ 0.800
NBV Per Share(RMB)* ¥ 13.009
Market Capitalization(RMB) 40.045B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.